<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="anthelminthic/PMC7697925/results/search/disease/results.xml">
  <result pre="Introduction Fungal infections, such as human invasive aspergillosis, candidiasis, or" exact="cryptococcosis" post="caused by Aspergillus, Candida, or Cryptococcus species, respectively, are"/>
  <result pre="the saprobic/dimorphic Paracoccidioides species, a causative agent of the systemic" exact="mycosis" post="paracoccidioidomycosis, which adopted three additional steps: (a) identification of"/>
  <result pre="various animal models and infection routes, together with various immune" exact="suppression" post="regimens. Examples include, but are not limited to, drug"/>
  <result pre="mucormycosis, persistently neutropenic rabbit model for investigating acute, invasive pulmonary" exact="aspergillosis" post="(IPA), and persistently granulocytopenic rabbit model for characterizing the"/>
  <result pre="to the host (in vivo) and preventing the establishment of" exact="meningoencephalitis" post="[236]. The fact that the in vitro antifungal activity"/>
  <result pre="Overcoming regulatory and financial hurdles in repurposing approved drugs as" exact="cancer" post="therapeuticsFront. Oncol.2017710.3389/fonc.2017.0027329184849 14.collab: National Center for Biotechnology InformationPubMedAvailable online:"/>
  <result pre="online: https://www.ncbi.nlm.nih.gov/pubmed(accessed on 14 August 2020) 15.De OliveiraA.A.NevesB.J.SilvaL.D.C.SoaresC.M.D.A.AndradeC.H.PereiraM.Drug repurposing for" exact="paracoccidioidomycosis" post="through a computational chemogenomics frameworkFront. Microbiol20191010.3389/fmicb.2019.0130131244810 16.KhedrM.A.MassarottiA.MohamedM.E.Rational discovery of"/>
  <result pre="pombe model organismKobe J. Med. Sci.201561E54E6326628015 47.MuthularM.BálsamoF.PasseroP.JewtuchowiczV.MiozzaV.VillalbaM.B.BruscaM.I.PérezC.Effects of tamoxifen on" exact="periodontal disease" post="and Candida albicans of patients with breast cancer and"/>
  <result pre="tamoxifen on periodontal disease and Candida albicans of patients with" exact="breast cancer" post="and other pathologiesFuture Microbiol.20191412913710.2217/fmb-2018-027230672328 48.HaiT.P.VanA.D.NganN.T.T.NhatL.T.H.LanN.P.H.ChauN.V.V.ThwaitesG.E.KrysanD.DayJ.N.The combination of tamoxifen with"/>
  <result pre="on periodontal disease and Candida albicans of patients with breast" exact="cancer" post="and other pathologiesFuture Microbiol.20191412913710.2217/fmb-2018-027230672328 48.HaiT.P.VanA.D.NganN.T.T.NhatL.T.H.LanN.P.H.ChauN.V.V.ThwaitesG.E.KrysanD.DayJ.N.The combination of tamoxifen with"/>
  <result pre="Discovery of new benzocyclane derivatives as potent antifungal agents against" exact="cryptococcosis" post="and candidiasisACS Infect. Dis.2020676878610.1021/acsinfecdis.9b0019731550886 79.StylianouM.KulesskiyE.LopesJ.P.GranlundM.WennerbergK.UrbanC.F.Antifungal application of nonantifungal drugsAntimicrob."/>
  <result pre="for new antifungal agentsMeth. Protoc.201923110.3390/mps202003131164611 105.ClarkA.HemmelgarnT.Danziger-IsakovL.TeusinkA.Intravenous pentamidine for Pneumocystis carinii/jiroveci" exact="pneumonia" post="prophylaxis in pediatric transplant patientsPediatr. Transplant.20151932633110.1111/petr.1244125712369 106.LiW.ZhangZ.-W.LuoY.LiangN.PiX.-X.FanY.-M.Molecular epidemiology, in"/>
  <result pre="against multidrug resistant Candida auris identified in the medicines for" exact="malaria" post="venture’s pathogen boxJ. Fungi201959210.3390/jof5040092 120.WuY.GrossmanN.TottenM.MemonW.FitzgeraldA.YingC.ZhangS.X.Antifungal susceptibility profiles and drug"/>
  <result pre="pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary" exact="aspergillosis" post="and mucormycosisAntimicrob. Agents Chemother.2014586767677210.1128/AAC.03569-1425182639 140.HomaM.GalgóczyL.TóthE.TóthL.PappT.ChandrasekaranM.KadaikunnanS.AlharbiN.S.VágvölgyiC.In vitro antifungal activity of"/>
  <result pre="the antifungal arsenalVirulence2017819821010.1080/21505594.2016.121628327459018 148.JungE.H.MeyersD.J.BoschJ.CasadevallA.Novel antifungal compounds discovered in medicines for" exact="malaria" post="venture’s malaria boxmSphere2018310.1128/mSphere.00537-1729564402 149.MontoyaM.C.DiDoneL.HeierR.F.MeyersM.J.KrysanD.J.Antifungal Phenothiazines: Optimization, characterization of mechanism,"/>
  <result pre="arsenalVirulence2017819821010.1080/21505594.2016.121628327459018 148.JungE.H.MeyersD.J.BoschJ.CasadevallA.Novel antifungal compounds discovered in medicines for malaria venture’s" exact="malaria" post="boxmSphere2018310.1128/mSphere.00537-1729564402 149.MontoyaM.C.DiDoneL.HeierR.F.MeyersM.J.KrysanD.J.Antifungal Phenothiazines: Optimization, characterization of mechanism, and modulation"/>
  <result pre="on 21 August 2020) 173.LawG.L.Tisoncik-GoJ.KorthM.J.KatzeM.G.Drug repurposing: A better approach for" exact="infectious disease" post="drug discovery?Curr. Opin. Immunol.20132558859210.1016/j.coi.2013.08.00424011665 174.AbadioA.K.R.KioshimaE.S.TeixeiraM.M.MartinsN.F.MaigretB.FelipeM.S.S.Comparative genomics allowed the identification"/>
  <result pre="asahii, T. asteroides and T. inkinVirulence2015647648610.1080/21505594.2015.102027325751127 225.PaulussenC.BouletG.A.V.CosP.DelputteP.MaesL.J.R.M.Animal models of invasive" exact="aspergillosis" post="for drug discoveryDrug Discov. Today2014191380138610.1016/j.drudis.2014.06.00624931219 226.collab: National Research Council"/>
  <result pre="female, 4 to 6 weeks old;immunosuppression model of murine oropharyngeal" exact="candidiasis" post="C. albicans Preventive deferasirox treatment significantly reduced the fungal"/>
 </snippets>
</snippetsTree>
